Thumbay International Research Grant’s 1st cycle awards AED 3 mn to 14 global healthcare projects
Gulf Medical University (GMU) capped its Annual Research Day with the grand conclusion of the inaugural Thumbay International Research Grant (TIRG), distributing AED 3 million across 14 pioneering projects selected from 192 submissions representing 34 universities worldwide. Supported by Thumbay Group UAE, the scheme aims to position GMU as a global hub for collaborative healthcare research.
Sheikh Ammar bin Humaid Al Nuaimi, Crown Prince of Ajman, was represented at the ceremony by Sheikh Majeed bin Saeed Al Nuaimi, chairman, Ruler’s Court, who personally presented the awards. Projects span key areas including Precision Medicine, Drug Discovery and Cancer Immunology, Population Health, Healthy Aging and Regenerative Medicine, AI and Digital Transformation in Healthcare, Health Economics, and Innovation in Health Professions Education.
“We launched this grant to transform Gulf Medical University into a hub for Research,” said Thumbay Moideen, founder, GMU and President of Thumbay Group, who also announced that total funding will rise to AED 10 million over the next three years, underlining a sustained commitment to research excellence.
“The diversity and quality of submissions reflect GMU’s growing global reputation. We are proud to support research that has the potential to transform healthcare and elevate lives,” said Prof Manda Venkatramana, acting chancellor, GMU.
Prof Saleem Chouib, vice chancellor, Research, GMU, “The quality and originality of the selected research projects are truly exceptional, showcasing the innovative spirit of global academia. The Thumbay International Research Grant is a powerful catalyst for groundbreaking research and international collaboration,”
2025 TIRG Awardees (by Domain and Lead Institution)
|
Domain
|
Lead Institution
|
Project Title
|
|---|---|---|
|
Health Professions Education
|
Harvard Medical School, USA
|
Integrating Clinical Neurology Rx Bricks into Preclinical Neuroscience Education: Impact on Engagement, Learning Outcomes, and Neurophobia
|
|
Artificial Intelligence
|
University of Arizona, USA
|
Leveraging Global Flu View for AI‑Driven Digital Transformation in Healthcare
|
|
Population Health
|
University of Waterloo, Canada
|
Advancing Health Assessment for Older Adults–Middle East and North Africa Utilization of Lay Assessment Systems (MENAULAS)
|
|
Precision Medicine
|
Regensburg University, Germany
|
Establishing Novel Therapeutic Strategies to Enhance Cancer Cell Reactivity to Targeting and Immune Therapies
|
|
Precision Medicine
|
Policlinico Ospedali Riuniti, Italy
|
Hypoxia Gene Signature as a Promising Biomarker to Improve Pancreatic Cancer Patient Management
|
|
Precision Medicine
|
Lebanese University, Lebanon
|
A Prospective Clinical Study on Minimally Invasive Implantology Techniques for Sites with Limited Bone Height and Narrow Ridges
|
|
Precision Medicine
|
Beirut Arab University, Lebanon
|
Comparative Study on the Effects of Waterpipe and Cigarette Smoking: Metabolomics and Tumorigenic Effects
|
|
Precision Medicine
|
Alexandria University, Egypt
|
A Precision Medicine Approach for Predicting Immunotherapy Response in HCC: Integrating Molecular PD‑L1 Profiling, Clinical Data and Machine Learning
|
|
Drug Discovery & Precision Med.
|
RAK Medical & Health Sciences University, UAE
|
Precision Trojan Horse Approach for Triple‑Negative Breast Cancer: Dual‑Loaded Doxorubicin and Dapagliflozin PEGylated Nanoparticles Targeting CD44‑Positive Cancer Stem Cells and Immune Evasion Pathways
|
|
Precision Medicine
|
MBRU, UAE
|
Disrupting the TRIM28 Complex: A Potential Combination Therapy with Immune Checkpoint Inhibitors in TNBC
|
|
Precision Medicine
|
Ajman University, UAE
|
The Role of Vorinostat and CID1067700 in Skin Regeneration and Wound Healing
|
|
Precision Medicine
|
University of Sharjah, UAE
|
Alleviating Hypoxia as a Means of Improving Pancreatic Cancer’s Response to Immunotherapy
|
|
Precision Medicine
|
Al Ain University, UAE
|
Targeting Metabolism for Personalised Improvement of Chemotherapeutic Efficacy in Breast Cancer
|
link
